Shares of Gland Pharma fell up to 6% to the day’s low of Rs 1,745 on BSE in Tuesday’s trade after entities related to ex-promoter Dr Ravi Penmetsa likely sold 5.5% equity in the company. Large block deals of nearly 91 lakh shares were reported today in which shares worth about Rs 1,600 crore changed … Read more
Shares of Gland Pharma on Tuesday rallied up to 20% to the day’s high of Rs 1,610 after the company reported better-than-expected June quarter earnings with revenue growing 41% year-on-year (YoY). Global brokerage firm Jefferies upgraded the stock to buy from underperform with an increased price target of Rs 1,640 from Rs 1,065 earlier. Bernstein … Read more
New Delhi: Shares of dropped 15% during the trading session on Thursday, registering its biggest intra-day loss in more than two years of listing at the bourses following a disappointing Q2 performance. The drug maker, which announced its results for the September 2022 quarter, reported a 20% year-on-year (YoY) decline in consolidated net profit at … Read more